Improvement Diagnosis and Treatment of Mantle Cell Lymphoma in a Middle-Income Country: A Time-Dependent Analysis in Mexico

Autor: Rangel-Patiño, Juan, Colunga-Pedraza, Perla R.R., Agreda, Gladys P, Aguirre-Reyes, Oyuky Gissell, Gomez-Almaguer, David, Ramirez-Ibarguen, Ana Florencia
Zdroj: Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p3051-3051, 1p
Abstrakt: Introduction:Mantle cell lymphoma (MCL) is a non-Hodgkin lymphoma representing 4-9% of all lymphomas. The disease prognosis remains adverse. However, diagnosis and treatment of MCL have undergone a significant improvement in the last years.
Databáze: Supplemental Index